LYFECYCLE
29.8.2021 11:50:06 CEST | Business Wire | Press release
Lyfecycle has teamed up with plant-based burger chain Neat Burger and Extreme E, the electric offroad racing series, on a mission to build greater awareness about plastic pollution and the need for action, through the creation of a ‘Reach for Change’ limited edition bracelet.
Lyfecycle, created by British innovators Polymateria, aims to tackle the global plastic pandemic. Lyfecycle’s unique technology allows every chance for recycling to happen and offers a “Plan B” for the 32 per cent of plastic that escapes the circular economy and winds up in the natural environment. Through time-set biodegradation, Lyfecycle products return to nature in a little over a year, leaving no toxins or microplastics behind, compared to the thousands of years it is estimated that typical plastics take to break down.
It is estimated that the Arctic Ocean ice contains 12,000 particles of microplastic per litre – higher than in any other ocean in the world. Scientists predict that over time these small particles trap heat within sea ice, which accelerates melting associated with global climate change.
Inspired by nature and powered by science, the ‘Reach for Change’ bracelet features one-of-a-kind sustainable beads repurposed from Lyfecycle cups used at Extreme E’s Arctic X Prix, an adjustable cord from recovered plastic bottles, and a recycled fair trade silver emblem. It is a tangible example of how Lyfecycle materials designed for biodegradation can also be upcycled into high value items such as jewellery thanks to the unique time-set biodegradation property. Redefining the way we think about and design plastics is essential if we are to solve the plastic pandemic.
All bracelets also come with some educational facts about plastic pollution and the steps we can all adopt to help us to lower our daily usage, and recycle more. It serves as a daily reminder that small actions when multiplied by millions contribute to a big change.
The campaign is set to launch during the 2021 Extreme E race in Kangerlussuaq, where attendees will be asked to get involved and help spread the message.
The competition will also be extended to Game Changers across the world, who are taking small steps toward making a positive impact on the environment. Consumers are encouraged to enter for a chance to win at www.lyfecycle.com/reachforchange . 50 winners will be announced on September 15, 2021. Each winner will receive two bracelets, one for themselves and one to gift to another Game Changer.
Niall Dunne, CEO of Polymateria said: “Our collaboration with fellow disruptors Neat Burger and Extreme E is to provide industry with an example of how recycling and biodegradation can work together and put consumers at the heart of the type of change we need to see to address plastic pollution at scale.”
Alejandro Agag, Founder and CEO of Extreme E said: “Extreme E is a platform to accelerate change. We bring disruptive innovators together and push boundaries not only in motorsport but across all industries. It is the adoption of new technologies that we want to promote because they have the power to improve our world.
“Lyfecycle is a great example of a solution to plastic pollution that works and can be scaled immediately whereas the limited-edition bracelet is a reminder that everyone has a role to play and action has to come from every corner.”
Stasi Nychas, Co-Founder and COO at Neat Burger said: “We are delighted to team up with Lyfecycle on a campaign that echoes our values. As the world’s first plant-based sustainable burger chain, we are committed to championing environmental sustainability and playing our part in positively impacting the environment. Therefore, we are proud to have partnered with Lyfecycle, whose team is dedicated to spreading awareness and promoting solutions to plastic pollution.”
NOTES TO EDITORS
About Lyfecycle:
Lyfecycle is a new solution from British Innovators Polymateria to tackle the global plastic pandemic. The unique Lyfecycle technology allows every chance for recycling to happen and offers a “Plan B” for the 32% of plastic that escapes the circular economy and winds up in the natural environment. Through time-set biodegradation, Lyfecycle products return to nature in a little over a year leaving no toxins and microplastics behind.
Lyfecycle packaging solutions give individuals a more easily achievable way to take small actions toward responsible disposal that will have an immediate and global positive impact on the environment. Through collaborative partnerships, awareness building, and scientific innovation, Lyfecycle’s goal is to ignite action and cause a ripple effect that will solve ocean pollution, and leave the planet in a better place for generations to come.
About Extreme E:
Extreme E is a radical new racing series, which will see electric SUVs competing in extreme environments around the world which have already been damaged or affected by climate and environmental issues. The five-race global voyage highlights the impact of climate change and human interference in some of the world’s most remote locations and promotes the adoption of electric vehicles in the quest for a lower carbon future for the planet.
About Neat Burger:
Founded in collaboration with F1 legend Lewis Hamilton, the group is loved by plant-based and meat eaters alike, serving up a fresh approach to vegan dining while satisfying everyone’s craving for American style food that tastes just like the real thing. Neat Burger works in association with The Eden Projects where for every product sold, a tree is planted.
About Anchor & Crew:
Combining British craft manufacturing with a discerning modern-minimalist style, ANCHOR & CREW is a jewellery and accessories brand that is both multi-award winning ever since 2014 and believers in having a highly ethical and traceable supply chain. ANCHOR & CREW is driven to empower consumers to make the right choice with radical transparency and enact change within their industry.
Honorable Mentions:
Carbon-neutral cup supplier Cupstorys, Imperial College London, Protolabs, and Lyfecycle’s own innovation labs that made this unique piece of jewellery possible.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210829005016/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
